A senior executive of Nanjing Insititute of Surveying, Mapping & Geotechnical Investigation Co. Ltd (stock code 300826.SZ) plans to reduce their holdings by no more than 60,000 shares.
Surveying and mapping shares (300826.SZ) announced that Mr. Liu Jian, a senior management personnel of the company, plans to reduce his holdings of the company's shares by no more than 60,000 shares (0.03% of the total share capital of the company) through centralized bidding within 3 months after 15 trading days from the disclosure date of this announcement (from July 9, 2026 to October 8, 2026).
Nanjing Institute of Surveying, Mapping & Geotechnical Investigation, Co. Ltd (300826.SZ) announced that Mr. Liu Jian, a senior management member of the company, plans to reduce his holdings of the company's shares by no more than 60,000 shares (0.03% of the total share capital of the company) through centralized bidding within 3 months after the disclosure of this announcement, starting from the 15th trading day after the announcement until October 8, 2026.
Related Articles
IMMUNEONCO-B (01541) spent HK$592,500 to repurchase 163,200 shares on June 16.
Hubei Heyuan Gas Co., Ltd. (002971.SZ): Qian Tu privately reduces holdings to below 5%, planning to continue reducing holdings by no more than 1% of the shares.
Jiangsu Hengrui Pharmaceuticals' independently developed CDK4/6 inhibitor hydroxyethyl sulfonate dalsalic tablets has received approval for new indications by the National Medical Products Administration.
IMMUNEONCO-B (01541) spent HK$592,500 to repurchase 163,200 shares on June 16.
Hubei Heyuan Gas Co., Ltd. (002971.SZ): Qian Tu privately reduces holdings to below 5%, planning to continue reducing holdings by no more than 1% of the shares.
Jiangsu Hengrui Pharmaceuticals' independently developed CDK4/6 inhibitor hydroxyethyl sulfonate dalsalic tablets has received approval for new indications by the National Medical Products Administration.
RECOMMEND
